Literature DB >> 33715228

Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.

Camila F Almeida1,2, Marc Bitoun2, Mariz Vainzof1.   

Abstract

Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD-CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI-Dnm2R465W/+ mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI-Dnm2R465W/+ mouse model for AD-CNM. We found a reduced number of Pax7-positive SCs, which were also less activated after induced muscle injury. The muscles of the KI-Dnm2R465W/+ mouse regenerated more slowly and less efficiently than wild-type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI-Dnm2R465W/+ mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle-specific impact occurring in AD-CNM.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  GTPase; congenital; injury; muscle; stem cell

Year:  2021        PMID: 33715228     DOI: 10.1096/fj.202001313RRR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

Review 1.  Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.

Authors:  Kenshiro Fujise; Satoru Noguchi; Tetsuya Takeda
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

2.  Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies.

Authors:  Massimo Ganassi; Francesco Muntoni; Peter S Zammit
Journal:  Exp Cell Res       Date:  2021-11-03       Impact factor: 3.905

Review 3.  Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.

Authors:  Raquel Gómez-Oca; Belinda S Cowling; Jocelyn Laporte
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

4.  Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy.

Authors:  Delphine Trochet; Bernard Prudhon; Lylia Mekzine; Mégane Lemaitre; Maud Beuvin; Laura Julien; Sofia Benkhelifa-Ziyyat; Mai Thao Bui; Norma Romero; Marc Bitoun
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-13       Impact factor: 8.886

5.  Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations.

Authors:  Swati Dudhal; Lylia Mekzine; Bernard Prudhon; Karishma Soocheta; Bruno Cadot; Kamel Mamchaoui; Delphine Trochet; Marc Bitoun
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-13       Impact factor: 10.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.